Based on the title, the paper reports using mobile EEG in Peru to derive scalable biomarkers for Parkinson's disease; the abstract is not provided.

Low-cost, portable EEG biomarkers could enable broader screening, remote monitoring, and patient stratification for clinical trials—useful translational tools even though they do not directly illuminate therapeutic mechanisms.